3Troen B R. Molecular mechanisms underlying osteoclast formation and and action[J]. Exp Gerontol, 2003, 38: 605- 614.
4Matsumoto A, Yamaji K, Kawani M. Effect of aging on bone formation induced by recombinant human bone morphogenetic protein-2 combined with fibrous collagen membrances at subperiosteal sites [J]. Periodontal Res, 2001, 36:175-182.
6Kapturczak MH, Flotte T, Atkinson MA, et al. Adenoassociated virus (AAV) as a vehicle for therapeutic genedelivery: improvements in vectors design and viral production enhance potential to prolong graft survival in pancreatic islet cell transplantation for the reversal of type 1 diabetes[J]. Curt Mol Med, 2001, 1:245.
7Lou J, Xu F, Merkel K,et al. Gene therapy: adenovirus-mediated human bone morphogenetic protein-2 gene transfer induces mesenchymal progenitor cell proliferation and differentiation in vitro and bone formation in vivo. J Orthop Res, 1999,17(1):43-50.
8Ganly I, Kirn D, Eckhardt G, et al. A phase I study of Onyx-015, an E1B attenuated adenovirus, administered intratumorally to patients with recurrent head and neck cancer. Clin Cancer Res, 2000,6(3):798-806.
9Harvey BG, Worgall S, Ely S, et al. Cellular immune responses of healthy individuals to intradermal administration of an E1-E3- adenovirus gene transfer vector. Hum Gene Ther, 1999,10(17):2823-2837.
10Nikitina EY, Chada S, Muro-Cacho C, et al. An effective immunization and cancer treatment with activated dendritic cells transduced with full-length wild-type p53. Gene Ther, 2002, 9(5):345-352.
